I agree that this site is using cookies. You can find further informations here.
X
Cottu, Paul
401  results:
Search for persons X
?
1

Prevalence and survival implications of malnutrition and sa..:

Camilleri, Géraldine M. ; Delrieu, Lidia ; Bouleuc, Carole...
Clinical Nutrition.  43 (2024)  8 - p. 1710-1718 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Advanced prescription of injectable anticancer drugs: Safet..:

Acramel, Alexandre ; Blondeel‐Gomes, Sandy ; Dupré, Mathilde...
British Journal of Clinical Pharmacology.  90 (2024)  5 - p. 1333-1343 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Association between endocrine adjuvant therapy intake timin..:

Giacchetti, Sylvie ; Laas, Enora ; Bachelot, Thomas...
eBioMedicine.  104 (2024)  - p. 105141 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Sacituzumab govitecan in metastatic triple-negative breast ..:

De Moura, Alexandre ; Loirat, Delphine ; Vaillant, Sarah...
Breast Cancer.  31 (2024)  4 - p. 572-580 , 2024
Link: https://doi.org/10.1007/..
 
?
5

The prognosis of patients treated with everolimus for advan..:

Salaün, Hélène ; Djerroudi, Lounes ; Haik, Laura...
The Journal of Pathology: Clinical Research.  10 (2024)  3 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
6

Fulvestrant and everolimus efficacy after CDK4/6 inhibitor:..:

Vasseur, Antoine ; Cabel, Luc ; Hego, Caroline...
Oncogene.  43 (2024)  16 - p. 1214-1222 , 2024
Link: https://doi.org/10.1038/..
 
?
7

TROP2, androgen receptor, and PD‐L1 status in histological ..:

Chartier, Suzanne ; Brochard, Camille ; Martinat, Charlotte...
Histopathology.  82 (2023)  5 - p. 664-671 , 2023
Link: https://doi.org/10.1111/..
 
?
8

Outcomes and toxicity of concurrent CDK4/6 inhibitor and lo..:

Beddok, Arnaud ; Mouren, Victoire ; Cottu, Paul...
International Journal of Cancer.  153 (2023)  7 - p. 1386-1396 , 2023
Link: https://doi.org/10.1002/..
 
?
9

Pattern and risk factors of isolated local relapse among wo..:

Rassy, Elie ; Filleron, Thomas ; Viansone, Alessandro...
Breast Cancer Research and Treatment.  199 (2023)  2 - p. 371-379 , 2023
Link: https://doi.org/10.1007/..
 
?
10

CANTO skin: Evaluation of skin toxicity risk factors in pat..:

Allali, Sofiane ; Carton, Matthieu ; Everhard, Sibille...
International Journal of Cancer.  153 (2023)  10 - p. 1797-1808 , 2023
Link: https://doi.org/10.1002/..
 
?
11

[18F]FDG PET/CT for predicting triple-negative breast cance..:

Seban, Romain-David ; Arnaud, Emilie ; Loirat, Delphine...
European Journal of Nuclear Medicine and Molecular Imaging.  50 (2023)  13 - p. 4024-4035 , 2023
Link: https://doi.org/10.1007/..
 
?
12

Baseline quality of life and chemotherapy toxicities in pat..:

Licaj, Idlir ; Coquan, Elodie ; Dabakuyo‐Yonli, Tienhan Sandrine...
Cancer.  129 (2023)  7 - p. 1085-1095 , 2023
Link: https://doi.org/10.1002/..
 
?
13

Long Terms Follow-Up of the Randomized MetaspHER Study Comp..:

Pivot, Xavier ; Spano, Jean-Philippe ; Espie, Marc...
Clinical Breast Cancer.  23 (2023)  7 - p. e412-e419 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Long-Term Results with Everolimus in Advanced Hormone Recep..:

François-Martin, Hélène ; Lardy-Cléaud, Audrey ; Pistilli, Barbara...
Cancers.  15 (2023)  4 - p. 1191 , 2023
Link: https://doi.org/10.3390/..
 
?
15

Oxidative phosphorylation is a metabolic vulnerability of e..:

El-Botty, Rania ; Morriset, Ludivine ; Montaudon, Elodie...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
1-15